Insider Selling: Cigna Corporation (CI) Insider Sells $1,680,083.84 in Stock
Cigna Corporation (NYSE:CI) insider Christopher J. Hocevar sold 8,387 shares of the company’s stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $200.32, for a total transaction of $1,680,083.84. Following the completion of the sale, the insider now directly owns 12,363 shares of the company’s stock, valued at $2,476,556.16. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Shares of Cigna Corporation (NYSE:CI) opened at $208.41 on Friday. Cigna Corporation has a one year low of $131.03 and a one year high of $212.46. The company has a market cap of $52,179.78, a P/E ratio of 20.39, a P/E/G ratio of 1.62 and a beta of 0.50. The company has a current ratio of 0.39, a quick ratio of 0.39 and a debt-to-equity ratio of 0.37.
Cigna (NYSE:CI) last released its earnings results on Thursday, November 2nd. The health services provider reported $2.83 EPS for the quarter, beating the consensus estimate of $2.36 by $0.47. Cigna had a net margin of 5.74% and a return on equity of 18.85%. The business had revenue of $10.38 billion during the quarter, compared to analyst estimates of $10.17 billion. During the same period in the prior year, the business earned $1.94 earnings per share. The business’s quarterly revenue was up 5.1% on a year-over-year basis. equities analysts predict that Cigna Corporation will post 10.34 EPS for the current year.
Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Cigna by 2.5% during the second quarter. Vanguard Group Inc. now owns 17,130,735 shares of the health services provider’s stock valued at $2,867,514,000 after acquiring an additional 424,469 shares during the period. FMR LLC raised its holdings in shares of Cigna by 6.7% during the second quarter. FMR LLC now owns 6,909,638 shares of the health services provider’s stock valued at $1,156,604,000 after acquiring an additional 432,978 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Cigna by 40.8% during the second quarter. JPMorgan Chase & Co. now owns 4,088,728 shares of the health services provider’s stock valued at $684,413,000 after acquiring an additional 1,184,632 shares during the period. Ameriprise Financial Inc. raised its holdings in shares of Cigna by 4.8% during the third quarter. Ameriprise Financial Inc. now owns 3,776,414 shares of the health services provider’s stock valued at $705,889,000 after acquiring an additional 171,712 shares during the period. Finally, TIAA CREF Investment Management LLC raised its holdings in shares of Cigna by 5.2% during the second quarter. TIAA CREF Investment Management LLC now owns 3,655,875 shares of the health services provider’s stock valued at $611,957,000 after acquiring an additional 180,310 shares during the period. Institutional investors and hedge funds own 87.84% of the company’s stock.
A number of brokerages have recently weighed in on CI. Morgan Stanley upped their price target on shares of Cigna from $195.00 to $223.00 and gave the stock an “overweight” rating in a research note on Friday, November 3rd. Royal Bank Of Canada reissued an “outperform” rating and set a $220.00 target price (up from $185.00) on shares of Cigna in a research note on Friday, November 3rd. Citigroup increased their target price on shares of Cigna from $185.00 to $198.00 and gave the company a “buy” rating in a research note on Monday, August 7th. Jefferies Group reissued a “buy” rating and set a $190.00 target price (down from $199.00) on shares of Cigna in a research note on Friday, August 4th. Finally, Zacks Investment Research lowered shares of Cigna from a “buy” rating to a “hold” rating in a research note on Tuesday, August 8th. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $201.50.
COPYRIGHT VIOLATION NOTICE: “Insider Selling: Cigna Corporation (CI) Insider Sells $1,680,083.84 in Stock” was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark and copyright law. The legal version of this piece of content can be accessed at https://www.watchlistnews.com/insider-selling-cigna-corporation-ci-insider-sells-1680083-84-in-stock/1738582.html.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.